Reneo Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
26.33
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.57
|
-0.53
|
0.04
|
7.02%
|
|
2022-06-30
|
-0.58
|
-0.50
|
0.08
|
13.79%
|
|
2022-03-31
|
-0.54
|
-0.53
|
0.01
|
1.85%
|
|
2021-12-31
|
-0.57
|
-0.43
|
0.14
|
24.56%
|
|
2021-09-30
|
-0.47
|
-0.52
|
-0.05
|
-10.64%
|
|
2021-06-30
|
-0.38
|
-0.43
|
-0.05
|
-13.16%
|
|
2021-03-31
|
-0.38
|
-3.48
|
-3.10
|
-815.79%
|
|
2020-12-31
|
0.00
|
-0.26
|
-0.26
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.56
|
|
2021-12-31
|
-4.86
|
|
2020-12-31
|
-0.26
|